Biochemical Markers of Myocardial Damage for Early Diagnosis and Prognosis in Patients with Acute Coronary Syndromes

References

• Karlson B W, Herlitz J, Pettersson P, Ekvall H E, Hjalmarson A. Patients admitted to the emergency room with symptoms indicative of acute myo-cardial infarction. J Intern Med 1991; 230: 251–8
   PubMed Web of Science ®Google Scholar
• Karlson B W, Herlitz J, Wiklund O, Richter A, Hjalmarson A. Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room. Am J Cardiol 1991; 68: 171–5
   PubMed Web of Science ®Google Scholar
• Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coro-nary artery disease and the acute coro-nary syndromes (second of two parts). N Engl J Med 1992; 326: 310–18
   PubMed Web of Science ®Google Scholar
• Rutherford J D, Braunwald E. Chronic ischemic heart disease. Heart disease. A textbook of cardiovascular medicine, E Braunwald. WB Saunders Company, Philadelphia 1992; 1293–1364
   Google Scholar
• Hypertension and coronary heart disease. Classification and criteria forepidemiological studies. World Health Organization Technical Series 168, 1959; 3
   Google Scholar
• Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med 1992; 326: 342–50
   Google Scholar
• Falk E. Plaque rupture with severe pre-existing stenosis precipitating coro-nary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983; 50: 127–34
   PubMedGoogle Scholar
• Davies M J, Thomas A C. Plaque fissuring: the cause of acute myo-cardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985; 53: 363–73
   PubMedGoogle Scholar
• Falk E, Shah P K, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657–71
   PubMed Web of Science ®Google Scholar
• Alderman E L, Corley S D, Fisher L D, et al. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investi-gators and Staff. J Am Coll Cardiol 1993; 22: 1141–54
   PubMed Web of Science ®Google Scholar
• Ambrose J A, Tannenbaum M A, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Col! Cardiol 1988; 12: 56–62
   PubMed Web of Science ®Google Scholar
• Giroud D, Li J M, Urban P, Meier B, Rutishauer W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992; 69: 729–32
   PubMed Web of Science ®Google Scholar
• Thompson S G, Kienast J, Pyke S D, Haverkate F, van de Loo J C. Hemo-static factors and the risk of myo-cardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombo-sis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995; 332: 635–41
   PubMed Web of Science ®Google Scholar
• Maseri A, L'Abbate A, Baroldi G, et al. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of “preinfarction” angina. N Engl J Med 1978; 299: 1271–7
   PubMed Web of Science ®Google Scholar
• Zeiher A M, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Pro-gressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391–401
   PubMed Web of Science ®Google Scholar
• Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction: value of combined thrombolytic and vasodilatory therapy. N Engl J Med 1987; 317: 1055–9
   PubMed Web of Science ®Google Scholar
• de Feyter P J, Ozaki Y, Baptista J, et al. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation 1995; 92: 1408–13
   PubMed Web of Science ®Google Scholar
• Ambrose J A. Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarction: if the substrate is similar, why is the clinical presentation different?. J Am Coll Cardiol 1992; 19: 1653–8
   PubMed Web of Science ®Google Scholar
• DeWood M A, Stifter W F, Simpson C S, et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 1986; 315: 417–23
   PubMed Web of Science ®Google Scholar
• Charney R, Cohen M. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. Am Heart J 1993; 126: 937–45
   PubMed Web of Science ®Google Scholar
• DeWood M A, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural infarction. N Engl J Med 1980; 303: 897–902
   PubMed Web of Science ®Google Scholar
• Phibbs B. “Transmural” versus “subendocardial” myocardial infarction: anelectrocardiographic myth. J Am Coll Cardiol 1983; 1: 561–564
   PubMed Web of Science ®Google Scholar
• Cohen M, Xiong J, Parry G, et al. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. J Am Coll Cardiol 1993; 22: 1338–43
   PubMed Web of Science ®Google Scholar
• Betriu A, Heras M, Cohen M, Fuster V. Unstable angina: outcome according to clinical presentation. J Am Coll Cardiol 1992; 19: 1659–63
   PubMed Web of Science ®Google Scholar
• Anderson H V, Cannon C P, Stone P H, et al. One-year results of the Thrombo-lysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized com-parison of tissue-type plasminogen activator versus placebo and early in-vasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 1995; 26: 1643–50
   PubMed Web of Science ®Google Scholar
• André-Fouet X, Pillot M, Leizorovicz A, Finet G, Gayet C, Milon H. “Non-Q wave”, alias “nontransmural”, myo-cardial infarction: a specific entity. Am Heart J 1989; 117: 892–900
   PubMed Web of Science ®Google Scholar
• Nicod P, Gilpin E, Dittrich H, et al. Short- and long-tern clinical outcome after Q wave and non-Q wave myo-cardial infarction in a large patient population. Circulation 1989; 79: 528–536
   PubMed Web of Science ®Google Scholar
• Berger C J, Murabito J M, Evans J C, Anderson K M, Levy D. Prognosis after first myocardial infarction. Compari-son of Q-wave and non-Q-wave myo-cardial infarction in the Framingham Heart Study. JAMA 1992; 268: 1545–51
   PubMed Web of Science ®Google Scholar
• Lincoff A M, Topol E J. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993; 88: 1361–74
   Google Scholar
• Koren G T, Hasin Y, Appelbaum D, et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous strepto-kinase. N Engl J Med 1985; 313: 1384–89
   PubMed Web of Science ®Google Scholar
• Nidorf S M, Siu S C, Galambos G, Weyman A E, Picard M H. Benefit of late coronary reperfusion on ventri-cular morphology and function after myocardial infarction. J Am Coll Cardiol 1993; 21: 683–91
   PubMed Web of Science ®Google Scholar
• Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all rando-mised trials of more than 1000 patients. Lancet 1994; 343: 311–22
   PubMed Web of Science ®Google Scholar
• Rawles J. What is the likely benefit of earlier thrombolysis?. Eur Heart J 1996; 17: 991–95
   PubMed Web of Science ®Google Scholar
• de Boer M J, Hoorntje J C, Ottervanger J P, Reiffers S, Suryapranata H, Zijlstra F. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol 1994; 23: 1004–8
   PubMed Web of Science ®Google Scholar
• Vaitkus P T. Percutaneous transluminal coronary angioplasty versus thrombo-lysis in acute myocardial infarction: a meta-analysis. Clin Cardiol 1995; 18: 35–8
   PubMed Web of Science ®Google Scholar
• ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 1: 349–360
   Google Scholar
• Gruppo Italiano per lo Studio della Streptochinasi nell' Infartomiocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myo-cardial infarction. Lancet 1986; 2: 349–360
   PubMedGoogle Scholar
• Langer A, Goodman S, Topol E, et al. Late assessment of thrombolytic Efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction. J Am Coll Cardiol 1996; 27: 1327–32
   PubMed Web of Science ®Google Scholar
• Karlsson J-E, Berglund U, Björkholm A, et al. Thrombolysis with recombi-nant human tissue-type plasminogen activator during instability in coronary artery disease: Effect on myocardial ischemia and need for coronary re-vascularization. Am Heart J 1992; 124: 1419–26
   PubMed Web of Science ®Google Scholar
• Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994; 89: 1545–56
   PubMedGoogle Scholar
• Lewis D JW D, Archibald D, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983; 309: 396–403
   PubMed Web of Science ®Google Scholar
• The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827–30
   PubMed Web of Science ®Google Scholar
• Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy—I: Prevention of death, myocardial infarction, and stroke by prolonged anti-platelet therapy in various categories of patients. Br Med J 1994; 308: 81–106
   PubMed Web of Science ®Google Scholar
• Cohen M, Adams P C, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Synd-romes Research Group. Circulation 1994; 89: 81–8
   PubMed Web of Science ®Google Scholar
• Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988; 319: 1105–1111
   PubMed Web of Science ®Google Scholar
• Dunn C J, Sorkin E M. Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders. Drugs 1996; 52: 276–305
   PubMed Web of Science ®Google Scholar
• Fragmin during instability in coronary artery disease (FRISC) study group. Low molecular weight heparin during instability in coronary artery disease. Lancet 1996; 347: 561–68
   PubMed Web of Science ®Google Scholar
• The global use of strategies to open occluded coronary arteries (GUSTO) IIb investigateors. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996; 335: 775–82
   PubMed Web of Science ®Google Scholar
• Antman EM, for the TIMI 9B investigators. Hirudin in acute myo-cardial infarction. Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial. Circulation 1996; 94: 911–21
   PubMed Web of Science ®Google Scholar
• Théroux P, Waters D, Lam J, et al. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992; 327: 141–5
   PubMed Web of Science ®Google Scholar
• Gold H K, Torres F W, Garabedian H D, et al. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. J Am Coll Cardiol 1993; 21: 1039–47
   PubMed Web of Science ®Google Scholar
• Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990; 323: 147–52
   PubMed Web of Science ®Google Scholar
• Cohen M, Adams P C, Hawkins L, Bach M, Fuster V. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myo-cardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). Am J Cardiol 1990; 66: 1287–92
   PubMed Web of Science ®Google Scholar
• Rahimtola S H, Nunley D, Grunkemeir G, Tepley J, Lampert L, Starr A. Ten-year survival after coronary bypass surgery for unstable angina. N Engl J Med 1983; 308: 676–81
   PubMed Web of Science ®Google Scholar
• Myler R K, Shaw R E, Stertzer S H, et al. Unstable angina and coronary angio-plasty. Circulation 1990; 82: 1188–1195
   Web of Science ®Google Scholar
• Luchi R, Scott S, Deupree R. And the principal investigators and their associates of veterans administration cooperative study no. 28. Comparison of medical and surgical treatment for unstable angina pectoris. N Engl J Med 1987; 316: 977–84
   Google Scholar
• Karmen A, Wroblewski F, LaDue J S. Transaminase activity in human blood. J Clin Invest 1954; 34: 126–33
   Web of Science ®Google Scholar
• Wroblewski F, LaDue J S. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 1955; 90: 210–3
   PubMed Web of Science ®Google Scholar
• Dreyfus J C, Schapira G, Resnais J, Scebat L. La créatine-kinase sérique dans le diagnostic de l'infarctus myocardique. Rev Franc Etudes Clin Biol 1960; V: 386–387
   Google Scholar
• Roberts R. The two out of three criteria for diagnosis of infarction. Is it passe?. Chest 1984; 86: 511–13
   PubMed Web of Science ®Google Scholar
• Adams J D, Abendschein D R, Jaffe A S. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s?. Circulation 1993; 88: 750–63
   PubMed Web of Science ®Google Scholar
• Spieckermann P G, Nordbeck H, Preusse C J. From heart to plasma. Enzymes in cardiology, D J Hearse. John Wiley & sons, Chichester 1979; 81–95
   Google Scholar
• van Kreel B, van der Veen F, Willems G M, Hermens W T. Circulatory models in assessment of cardiac enzyme release in dogs. Am J Physiol 1993; 264: H747–54
   Google Scholar
• Piper H M, Schwartz P, Spahr R, Hutter J F, Spieckermann P G. Early enzyme release from myocardial cells is not due to irreversible cell damage. J Mol Cell Cardiol 1984; 16: 385–8
   PubMed Web of Science ®Google Scholar
• Heyndrickx G R, Amano J, Kenna T, et al. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol 1985; 6: 1299–303
   PubMed Web of Science ®Google Scholar
• Remppis A, Scheffold T, Greten J, et al. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 1995; 27: 793–803
   PubMed Web of Science ®Google Scholar
• Mair J, Dienstl F, Puschendorf B. Cardiac troponin T in the diagnosis of myocardial injury. Crit Rev Clin Lab Sci. 1992; 29: 31–57
   PubMed Web of Science ®Google Scholar
• Rabitzsch G, Mair J, Lechleitner P, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995; 41: 966–78
   PubMed Web of Science ®Google Scholar
• Mair J, Thorne-Kromer B, Wagner I, et al. Concentration time courses of tro-ponin and myosin subunits after acute myocardial infarction. Coron Artery Dis 1994; 5: 865–872
   PubMed Web of Science ®Google Scholar
• Sobel B E, Markham J, Karlsberg R P, Roberts R. The nature of dis-appearance of creatine kinase from the circulation and its influence on enzymativ estimation of infarct size. Circ Res 1977; 41: 836–844
   PubMed Web of Science ®Google Scholar
• Clark G L, Robison A K, Gnepp D R, Roberts R, Sobel B E. Effects of lymphatic transport of enzyme on plasma creatine kinase time-activity curves after myocardial infarction in dogs. Circ Res 1978; 43: 162–169
   PubMed Web of Science ®Google Scholar
• Blanke H, von Hardenberg D, Cohen M, et al. Paterns of creatine kinase release during acute myocardial infarction after nonsurgival reperfusion: Comparison with conventional treat-ment and correlation with infarct size. J Am Coll Cardiol 1984; 3: 675–680
   PubMed Web of Science ®Google Scholar
• Roberts R, Sobel B E. The distribution, inactivation and clearance of enzymes. Enzymes in Cardio-logy, D J Hearse. John Wiley & sons, Chichester 1979; 97–114
   Google Scholar
• Pesce M A. The CK and LD macro-enzymes. Lab Management 1984; 22: 29–41
   Google Scholar
• Gerhardt W, Bullock D, Duggan P, et al. ECCLS standards for enzyme determinations. Creatine Kinase, Aspartate Aminotransferase, Alanine Aminotransferase and gamma-Glutamyltransferase. Klinisk Kemi i Norden K. Hellsing 1990; vol 2: 5–88, suppl
   Google Scholar
• Gerhardt W, Ljungdahl L, Borjesson J, et al. Creatine kinase B-subunit activity in human serum. I. Development of an immunoinhibition method for routine determination of S-creatine kinase B-subunit activity. Clin Chim Acta 1977; 78: 29–41
   PubMed Web of Science ®Google Scholar
• Wu A H, Gornet T G, Harker C C, Chen H L. Role of rapid immunoassays for urgent (“stat”) determinations of creatine kinase isoenyme MB. Clin Chem 1989; 35: 1752–6
   PubMed Web of Science ®Google Scholar
• Puleo P R, Guadagno P A, Roberts R, et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation 1990; 82: 759–64
   PubMedGoogle Scholar
• Klocke F J, Copley D P, Krawczyk J A, Reichlin M. Rapid renal clearance of immunoreactive canine plasma myo-globin. Circulation 1982; 65: 1522–1528
   PubMed Web of Science ®Google Scholar
• Groth T, Sylvén C. Myoglobin kinetics in patients suffering from acute myocardial infarction in its early phase - as studied by the single injection methodw. Scand J Clin Lab Invest 1981; 41: 79–85
   PubMed Web of Science ®Google Scholar
• Roxin L-E, Venge P, Friman G, Hällgren R. Radioimmuneassays of human myoglobin in serum and urine. Scand. J Clin Lab Invest 1979; 39: 37–46
   PubMed Web of Science ®Google Scholar
• Mair J, Artner D E, Lechleitner P, et al. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J 1992; 68: 462–8
   PubMedGoogle Scholar
• Hein S, Scheffold T, Schaper J. Ischemia induces early changes to cyto-skeletal and contractile proteins in diseased human myocardium. J Thorac Cardiovasc Surg 1995; 110: 89–98
   PubMed Web of Science ®Google Scholar
• Katus H A, Scheffold T, Remppis A, Zehlein J. Proteins of the troponin complex. Laboratory Medicine 1992; 23: 311–17
   Web of Science ®Google Scholar
• Saggin L, Gorza L, Ausoni S, Schiaffino S. Cardiac troponin T in developing, regenerating and denervated rat skeletal muscle. Development 1990; 110: 547–54
   PubMed Web of Science ®Google Scholar
• Katus H A, Remppis A, Scheffold T, Diederich K W, Kuebler W. Intra-ceilular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and non-reperfused myocardial infarction. Am J Cardiol 1991; 67: 1360–7
   PubMed Web of Science ®Google Scholar
• Katus H A, Remppis A, Neumann F J, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902–12
   PubMed Web of Science ®Google Scholar
• Katus H A, Looser S, Haliermayer K, et al. Development and in vitro characterization of a new immuno-assay of cardiac troponin T. Clin Chem 1992; 38: 386–93
   PubMed Web of Science ®Google Scholar
• Müller-Bardoff M, Müller G, Hallermayer K, et al. Development and characterization of a specific immunoassay for cardiac troponin T. Eur Heart J 1994; 15: 4, (abstract)
   Google Scholar
• Adams J E, Schechtman K B, Landt Y, Ladenson J H, Jaffe A S. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40: 1291–95
   PubMed Web of Science ®Google Scholar
• Mair J, Genser N, Morandell D, et al. Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clinica Chimica Acta 1996; 245: 19–38
   PubMed Web of Science ®Google Scholar
• Larue C, Calzolari C, Bertinchant J P, Leclercq F, Grolleau R, Pau B. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 1993; 39: 972–9
   PubMed Web of Science ®Google Scholar
• Sox H C, Blatt M A, Higins M C, Marton K I. Medical decision making. Butterworths, Boston 1988
   Google Scholar
• Groth T L, Ljunghall S, De Verdier C H. Optimal screening for patients with hyperparathyroidism with use of serum calcium observations. A decision-theoretical analysis. Scand J Clin Lab Invest 1983; 43: 699–707
   PubMed Web of Science ®Google Scholar
• Cebul R D, Hershey J C, Williams S V. Using multiple tests: series and parallel approaches. Clin Lab Med 1982; 2: 871–90
   PubMedGoogle Scholar
• Leung F Y, Galbraith L V, Jablonsky G, Henderson A R. Re-evaluation of the diagnostic utility of serum total creatine kinase and creatine kinase-2 in myocardial infarction. Clin Chem 1989; 35: 1435–40
   PubMed Web of Science ®Google Scholar
• Zweig M H, Campbell G. Receiver-operating characteristics (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561–77
   PubMed Web of Science ®Google Scholar
• Lee T H, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Ann Intern Med 1986; 105: 221–33
   PubMed Web of Science ®Google Scholar
• Mair J, Artner D E, Dienstl A, et al. Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. Am J Cardiol 1991; 68: 1545–50
   PubMed Web of Science ®Google Scholar
• Bhayana V, Henderson A R. Bio-chemical markers of myocardial damage. Clin Biochem 1995; 28: 1–29
   PubMed Web of Science ®Google Scholar
• Roxin L E, Cullhed I, Groth T, Hallgren T, Venge P. The valueof serum myoglobin determinations in the early diagnosis of acute myocardial infarction. Acta Med Scand 1984; 215: 417–25
   PubMedGoogle Scholar
• Collinson P O, Ramhamadany E M, Rosalki S B, et al. Diagnosis of acute myocardial infarction from sequential enzyme measurements obtained within 12 hours of admission to hospital J Clin Pathol 1989; 42: 1126–31
   Google Scholar
• Wu A H, Gornet T G, Bretaudiere J P, Panfili P R. Comparison of enzyme immunoassay and immunoprecipitation for creatine kinase MB in diagnosis of acute myocardial infarction. Clin Chim 1985; 31: 470–474
   PubMed Web of Science ®Google Scholar
• Kock T R, Mehta U J, Nipper H C. Clinical and analytical evaluation of kits for measurements of creatine kinase isoenzyme MB. Clim Chem 1986; 32: 186–191
   PubMed Web of Science ®Google Scholar
• Wu A H, Valdes R J, Apple F S, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994; 40: 900–7
   PubMed Web of Science ®Google Scholar
• McComb J M, McMaster E A, MacKenzie G, Adgey A A. Myoglobin and creatine kinase in acute myocardial infarction. Br Heart J 1984; 51: 189–94
   PubMedGoogle Scholar
• Wu A H, Lane P L. Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases. Clin Chem 1995; 41: 1228–33
   PubMed Web of Science ®Google Scholar
• Lee H S, Cross S J, Garhwaite P, et al. Comparison of the value of novel rapid measurement of myoglobin, creatine kinase, and creatine kinase-MB with the electrocardiogram for the diagnosis of acute myocardial infarction. Br Heart J 1994; 71: 311–5
   PubMedGoogle Scholar
• Bakker A J, Koelemay M J, Gorgels J P, et al. Troponin T and myoglobin at ad-mission: value of early diagnosis of acute myocardial infarction. Eur Heart J 1994; 15: 45–53
   PubMed Web of Science ®Google Scholar
• Marin M M, Teichman S L. Use of rapid serial sampling of creatine kinase MB for very early detection of myo-cardial infarction in patients with acute chest pain. Am Heart J 1992; 123: 354–61
   PubMed Web of Science ®Google Scholar
• Van Blerk M, Maes V, Huyghens L, Derde M P, Meert R, Gorus F K. Analytical and clinical evaluation of creatine kinase MB mass assay by IMx: comparison with MB isoenzyme activity and serum myoglobin for early diagnosis of myocardial infarction. Clin Chem 1992; 38: 2380–6
   PubMed Web of Science ®Google Scholar
• Bakker A J, Koelemay M JW, Gorgels J PMC, et al. Failure of new biochemical markers to exclude acute myocardial infarction at admission. Lancet 1993; 342: 1220–22
   PubMed Web of Science ®Google Scholar
• Antman E M, Grudzien C, Sacks D B. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA 1995; 273: 1279–82
   PubMed Web of Science ®Google Scholar
• Puleo P R, Meyer D, Wathen C, et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994; 331: 561–6
   PubMed Web of Science ®Google Scholar
• Bodor G S, Porter S, Landt Y, Ladenson J H. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992; 38: 2203–14
   PubMed Web of Science ®Google Scholar
• Lessem J, Johansson B W, Nosslin B, Thorell J. Myocardial scintigraphy with 99mTc-pyrophosphate in patients with unstable angina pectoris. Acta Med Scand 1978; 203: 491–5
   PubMedGoogle Scholar
• Thygesen K, Hørder M, Krøll L, Petersen Hyltoft P, Haghfelt T. Creatine kinase and creatine kinase B-subunit in stable and unstable angina pectoris. Eur J Clin Invest 1986; 16: 1–4
   PubMed Web of Science ®Google Scholar
• Botker H E, Ravkilde J, Sogaard P, Jorgensen P J, Horder M, Thygesen K. Gradation of unstable angina based on a sensitive immunoassay for serum creatine kinase MB. Br Heart J 1991; 65: 72–6
   PubMedGoogle Scholar
• Isakov A, Shapira I, Burke M, Almog C. Serum myoglobin levels in patients with ischemic myocardial insult. Arch Intern Med 1988; 148: 1762–5
   PubMedGoogle Scholar
• Katus H A, Diederich K W, Hoberg E, Kubler W. Circulating cardiac myosin light chains in patients with angina at rest: identification of a high risk subgroup. J Am Coll Cardiol 1988; 11: 487–93
   PubMed Web of Science ®Google Scholar
• Gerhardt W, Katus H, Ravkilde J, et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem 1991; 37: 1405–11
   PubMed Web of Science ®Google Scholar
• Hamm C W, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146–50
   PubMed Web of Science ®Google Scholar
• Markenvard J, Dellborg M, Jagenburg R, Swedberg K. The predictive value of CKMB mass concentration in unstable angina pectoris: preliminary report. J Intern Med 1992; 231: 433–6
   PubMed Web of Science ®Google Scholar
• Ravkilde J, Horder M, Gerhardt W, et al. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest 1993; 53: 677–85
   PubMed Web of Science ®Google Scholar
• Pettersson T, Ohlsson O, Tryding N. Increased CKMB (mass concentration) in patients without traditional evidence of acute myocardial infarction. A risk indicator of coronary death. Eur Heart J 1992; 13: 1387–92
   PubMed Web of Science ®Google Scholar
• Ravkilde J, Nissen H, Hörder M, Thygesen K. Independent prognostic value of serum creatine kinase iso-enzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol 1995; 25: 574–81
   PubMed Web of Science ®Google Scholar
• White R D, Grande P, Califf L, Palmeri S T, Califf R M, Wagner G S. Diagnostic and prognostic significance of mini-mally elevated creatine kinase-MB in suspected acute myocardial infarction. Am J Cardiol 1985; 55: 1478–84
   PubMed Web of Science ®Google Scholar
• Hackel D B, Reimar K A, Ideker R E, et al. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation 1984; 70: 824–35
   PubMed Web of Science ®Google Scholar
• Roberts R. Enzymatic estimation of infarct size. Thrombolysis induced its demise: will it now rekindle its renais-sance?. Circulation 1990; 81: 707–10
   PubMed Web of Science ®Google Scholar
• Kawaguchi K, Sone T, Tsuboi H, et al. Quantitative estimation of infarct size by simultaneous dual radionuclide single photon emission computed tomography: comparison with peak serum creatine kinase activity. Am Heart J 1991; 121: 1353–60
   PubMed Web of Science ®Google Scholar
• Omura T, Teragaki M, Tani T, et al. Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarction. Jpn Circ J 1993; 57: 1062–70
   PubMedGoogle Scholar
• Devries S R, Jaffe A S, Geltman E M, Sobel B E, Abendschein D R. Enzymatic estimation of the extent of irreversible myocardial injury early after reperfusion. Am Heart J 1989; 117: 31–6
   PubMed Web of Science ®Google Scholar
• Groth T, Hakman M, Sylven C. Prediction of myocardial infarct size from early serum myoglobin observations. Scand J Clin Lab Invest 1987; 47: 599–603
   PubMed Web of Science ®Google Scholar
• Yamashita T, Abe S, Arima S, et al. Myocardial infarct size can be esti-mated from serial plasma myoglobin measurements within 4 hours of re-perfusion. Circulation 1993; 87: 1840–9
   PubMed Web of Science ®Google Scholar
• Zabel M, Hohnloser S H, Köster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous throm-bolysis. Circulation 1993; 87: 1542–1550
   PubMed Web of Science ®Google Scholar
• Puleo P R, Perryman M B. Noninvasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB sub-forms. J Am Coll Cardiol 1991; 17: 1047–52
   PubMed Web of Science ®Google Scholar
• Laperche T, Steg P G, Dehoux M, et al. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers. Circulation 1995; 92: 2079–86
   PubMed Web of Science ®Google Scholar
• Lott J A. Serum enzyme determinations in the diagnosis of acute myo-cardial infarction: an update. Hum Pathol 1984; 15: 706–16
   PubMed Web of Science ®Google Scholar
• Adams J D, Bodor G S, Davila R V, et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88: 101–6
   PubMed Web of Science ®Google Scholar
• Karlsberg R P, Roberts R. Effect of altered thyroid function in plasma creatine kinase clearance in the dog. Am J Physiol 1978; 235: 614–618
   Google Scholar
• Hällgren R, Cullhed I, Roxin L E, Venge P. Myoglobinemia after myocardial infarction; influence of renal function. Eur J Cardiol 1978; 8: 607–16
   PubMedGoogle Scholar
• Kobayashi S, Tanaka M, Tamura N, Hashimoto H, Hirose S. Serum cardiac troponin T in polymyositis/derma-tomyositis. Lancet 1992; 340: 8821
   Web of Science ®Google Scholar
• Katus H A, Haller C, Muller B M, Scheffold T, Remppis A. Cardiac troponin T in end-stage renal disease patients undergoing chronic main-tenance hemodialysis. Clin Chem 1995; 41: 1201–2
   PubMed Web of Science ®Google Scholar
• Dillon M C, Calbreath D F, Dixon A M, et al. Diagnostic problem in acute myocardial infarction: CK-MB in the absence of abnormally elevated total creatine kinase levels. Arch Intern Med 1982; 142: 33–8
   PubMedGoogle Scholar
• Adams J, Trent R, Rawles J. Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. The GREAT Group. Br Med J 1993; 307: 409–13
   PubMedGoogle Scholar
• Selwyn A P, Fox K, Welman E, Shillingford J P. Natural history and evolution of Q-waves during acute myocardial infarction. Br Heart J 1978; 40: 383–87
   PubMedGoogle Scholar
• Haiat R, Chiche P. Transient abnormal Q waves in the course of ischemic heart disease. Chest 1974; 65: 140–44
   PubMed Web of Science ®Google Scholar
• Boden W E, Gibson R S, Schechtman K B, et al. ST segment shifts arepoor predicvtors of subsequent Q wave evolution in acute myocardial infarction. A natural history study of early non-Q wave infarction. Circulation 1989; 79: 537–548
   PubMed Web of Science ®Google Scholar
• Yusuf S, Pearson M, Sterry H, et al. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial in-farction. Eur Heart J 1984; 5: 690–6
   PubMed Web of Science ®Google Scholar
• McGuiness J B, Begg T B, Semple T. First electrocardiogram in recent myo-cardial infarction. Br Med J 1976; 2: 449
   PubMedGoogle Scholar
• Cohen M, Scharpf S, Rentrop K. Pro-spectiveanalysis of electrocardio-graphic variables as markers for extent and location of acute wall motion ab-normalities observed during coronary angioplasty in human subjects. J Am Coll Cardiol 1987; 10: 17
   PubMedGoogle Scholar
• Mauri F, Gasparini M, Barbonaglia L, et al. Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial). Am J Cardiol 1989; 63: 1291–5
   PubMed Web of Science ®Google Scholar
• Cohen M, Hawkins L, Greenberg S, Fuster V. Usefulness of ST-segment changes in greater than or equal to 2 leads on the emergency room electro-cardiogram in either unstable angina pectoris or non-Q-wave myo-cardial infarction in predicting outcome. Am J Cardiol 1991; 67: 1368–73
   PubMed Web of Science ®Google Scholar
• Karlsson J E, Bjorkhoim A, Blomstrand P, Ohlsson J, Wallentin L. Ambulatory ST-recording has no additional value to exercise test for identification of severe coronary lesions after an episode of unstable coronary artery disease in men. Int J Card Imaging 1993; 9: 281–9
   PubMedGoogle Scholar
• Krucoff M W, Croll M A, Pope J E, et al. Continuous 12-lead ST-segment recovery analysis in the TAMI7 study. Performance of a noninvasive method for real-time detection of failed myo-cardial reperfusion. Circulation 1993; 88: 437–46
   PubMed Web of Science ®Google Scholar
• Dellborg M, Steg P G, Simoons M, et al. Vectorcardiographic monitoring to assess early vessel patency after reper-fusion therapy for acute myo-cardial infarction. Eur Heart J 1995; 16: 21–9
   PubMed Web of Science ®Google Scholar
• Lundin P, Eriksson S V, Strandberg L E, Rehnqvist N. Prognostic information from on-line vectorcardiography in acute myocardial infarction. Am J Cardiol 1994; 74: 1103–8
   PubMed Web of Science ®Google Scholar
• Patel D J, Holdright D R, Knight C J, et al. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 1996; 75: 222–228
   PubMed Web of Science ®Google Scholar
• Andersen K, Eriksson P, Källström G, Alveren E, Svensson A-M, Dellborg M. Contineuous vectorcardiography predicts clinical events in patients with unstable coronary disease. Eur Heart J 1996; 17: 575, (abstract)
   Google Scholar
• Lundin P, Eriksson S V, Fredrikson M, Rehnqvist N. Prognostic information from on-line vectorcardiography in unstable angina pectoris. Cardiology 1995; 86: 60–6
   PubMed Web of Science ®Google Scholar
• Butman S, Olson H, Butman L. Early exercise testing after stabilization of unstable angina: Correlation with coronary angiographic findings and subsequent cardiac events. Am Heart J 1986; 111: 11–18
   PubMed Web of Science ®Google Scholar
• Swahn E, Areskog M, Berglund U, Walfridsson H, Wallentin L. Predictive importance of clinical findings and a predischarge exercise test in suspected unstable coronary disease. Am J Cardiol 1987; 59: 208–14
   PubMed Web of Science ®Google Scholar
• Wilcox I, Freedman S B, Allman K C, et al. Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol 1991; 18: 677–83
   PubMed Web of Science ®Google Scholar
• Launbjerg J, Fruergaard P, Jacobsen H L, Madsen J K. Long-term risk factors from non-invasive evaluation of patients with acute chest pain, but without myocardial infarction. Eur Heart J 1995; 16: 30–7
   PubMedGoogle Scholar
• Nyman I, Wallentin L, Areskog M, Areskog N H, Swahn E. Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group. Int J Cardiol 1993; 39: 131–42
   PubMed Web of Science ®Google Scholar
• Swahn E, Areskog M, Wallentin L. Early exercise testing after coronary care for suspected unstable coronary artery disease - safety and diagnostic value. Eur Heart J 1986; 7: 594–601
   PubMed Web of Science ®Google Scholar
• Larsson H, Areskog M, Areskog N H, et al. Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction?. Int J Card Imaging 1991; 7: 7–14
   PubMedGoogle Scholar
• Juneau M, Colles P, Théroux P, et al. Symptom-limited versus low lewel exercise testing before hospital discharge after myocardial infarction. J Am Coll Cardiol 1992; 20: 927–33
   PubMed Web of Science ®Google Scholar
• Krone R, Dwyer E, Greenberg H, Miller J, Gillespie J. Risk stratification in patients with first non-Q-wave infarction: Limited value of the early low-level exercise test after uncom-plicated infarcts. J Am Coll Cardiol 1989; 14: 31–37
   PubMed Web of Science ®Google Scholar
• Amanullah A M, Lindvall K, Bevegard S. Prognostic significance of exercise thallium-201 myocardial perfusion imaging compared to stress echo-cardiography and clinical variables in patients with unstable angina who respond to medical treatment. Int J Cardiol 1993; 39: 71–8
   PubMed Web of Science ®Google Scholar
• van Daele M, McNeill A J, Fioretti P M, et al. Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyrid-amole stress echocardiography for new cardiac events after an uncom-plicated myocardial infarction. J Am Soc Echocardiogr 1994; 7: 370–80
   PubMedGoogle Scholar
• Larsson H. Myocardial ischemia as a risk indikator after an episode of unstable angina or non-Q-wave myo-cardial infarction. Thesis, Linköping 1991
   Google Scholar
• Schröder K, Völler H, Dingerkus H, et al. Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyri-damole, and dobutamine-atropine. Am J Cardiol 1996; 77: 909–14
   PubMed Web of Science ®Google Scholar
• Picano E, Landi P, Bolognese L, et al. Prognostic value of dipyridamole echocardiography early after uncom-plicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group. Am J Med 1993; 95: 608–18
   PubMed Web of Science ®Google Scholar
• Amanullah A, Lindvall K. Predischarge exercise echocardiography in patients with unstable angina who respond to medical treatment. Clin Cardiol 1992; 15: 417–423
   PubMed Web of Science ®Google Scholar
• Castaner A, Roig E, Serra A, et al. Risk stratification and prognosis of patients with recent onset angina. Eur Heart J 1990; 11: 868–75
   PubMed Web of Science ®Google Scholar
• Ahmed W H, Bittl J A, Braunwald E. Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina. Am J Cardiol 1993; 72: 544–50
   PubMed Web of Science ®Google Scholar
• Feld S, Ganim M, Carell E S, et al. Comparison of angioscopy, intra-vascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high risk patients. J Am Coll Cardiol 1996; 28: 97–105
   PubMed Web of Science ®Google Scholar
• Jansson P A. Neural Networks: An overview. Analytical Chemistry 1991; 63: 357 A–362 A
   Web of Science ®Google Scholar
• Baxt W G. Use of an artificial neural network for the diagnosis of myo-cardial infarction. Ann Intern Med 1991; 115: 843–8
   PubMed Web of Science ®Google Scholar
• Furlong J W, Dupuy M E, Heinsimer J A. Neural network analysis of serial cardiac enzyme data. A clinical app-lication of artificial machine intelli-gence. Am J Clin Pathol 1991; 96: 134–41
   PubMed Web of Science ®Google Scholar
• Gillum R F, Fortman S P, Prineas R J, Kottke T E. International diagnostic criteria for acute myocardial infarction and stroke. Am Heart J 1984; 108: 150–158
   PubMed Web of Science ®Google Scholar
• Jorgensen P J, Horder M, Selmer J, Botker H E. Analytical evaluation of a sensitive enzyme immunoassay for determinations of creatine kinase isoenzyme MB. Clin Chem 1990; 36: 1502–5
   PubMed Web of Science ®Google Scholar
• Gerhardt W, Katus H A, Ravkilde J, Hamm C W. S-troponin-Tas a marker of ischemic myocardial injury [letter]. Clin Chem 1992; 38: 1194–5
   PubMed Web of Science ®Google Scholar
• Karlsson J-E, Björkholm A, Nylander E, Ohlsson J, Swahn E, Wallentin L. ST-changes in ECG at rest or during exercise indicate a high risk of severe coronary lesions after an episode of unstable coronary artery disease. Int J Cardiol 1993; 42: 47–55
   PubMed Web of Science ®Google Scholar
• Roberts R, Kleiman N S. Earlier diagnosis and treatment of acute myo-cardial infarction necessitates the need for a ‘new diagnostic mind-set’. Circulation 1994; 89: 872–81
   PubMed Web of Science ®Google Scholar
• Lee T H, Juarez G, Cook E F, et al. Ruling out acute myocardial infarction. A prospective multicenter validation of a 12-hour strategy for patients at low risk. N Engl J Med 1991; 324: 1239–46
   PubMed Web of Science ®Google Scholar
• Brunelli C, Spallarossa P, Rosettin P, Caponetto S. Recognition and treat-ment of unstable angina. Drugs 1996; 52: 196–208
   PubMed Web of Science ®Google Scholar
• Jaffe A S. More rapid biochemical diagnosis of myocardial infarction: necessary? Prudent? Cost effective?. Clin Chem 1993; 39: 1567–9
   PubMed Web of Science ®Google Scholar
• Roxin L-E, Venge P, Wide L. A fast and sensitive radioimmunoassay of human myoglobin for use in the early diagnosis of heart infarction. Clinica Chimica Acta 1980; 107: 129–134
   PubMed Web of Science ®Google Scholar
• Cairns J A, Missirlis E, Walker W H. Usefulness of serial determinations of myoglobin and creatine kinase in serum compared for assessment of acute myocardial infarction. Clin Chem 1983; 29: 469–73
   PubMed Web of Science ®Google Scholar
• Mair J, Artner D E, Lechleitner P, et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991; 37: 845–52
   PubMed Web of Science ®Google Scholar
• Gunnar R M, Passamani E R, Bourdillon P D, et al. Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedu-res. J Am Coll Cardiol 1990; 16: 249–92
   PubMed Web of Science ®Google Scholar
• Anderson H, Dellborg M, Markenvard J, Jagenburg R, Herlitz J. [CK-MB is sufficient as a specific marker in the diagnosis of myocardial infarction]. Läkartidningen 1991; 88: 2890–2
   PubMedGoogle Scholar
• Newby L K, Gibler W B, Ohman E M, Christenson R H. Biochemical markers in suspected acute myocardial infarction: the need for early assessment. Clin Chem 1995; 41: 1263–5
   PubMed Web of Science ®Google Scholar
• Braunwald E, Cannon C. Non-Q wave and ST segment depression myo-cardial infarction: Is there a role for thrombolytic therapy?. J Am Coll Cardiol 1996; 27: 1333–34
   PubMed Web of Science ®Google Scholar
• Forsström J J, Irjala K, Selén G, et al. Using data preprocessing and single layer perceptron to analyse laboratory data. Scan J Clin Lab Invest 1995; 55(suppl)75–81
   Google Scholar
• Herlitz J, Hjalmarson A, Waldenstrom J. Time lapse from estimated onset of acute myocardial infarction to peak serum enzyme activity. Clin Cardiol 1984; 7: 433–40
   PubMed Web of Science ®Google Scholar
• Murphy J J, Connell P A, Hampton J R. Predictors of risk in patients with unstable angina admitted to a district general hospital. Br Heart J 1992; 67: 395–401
   PubMedGoogle Scholar
• Wallentin L, and the RISC group. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: Long term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. J Am Coll Cardiol 1991; 18: 1587–93
   PubMed Web of Science ®Google Scholar
• Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. Br Med J 1996; 313: 262–264
   PubMed Web of Science ®Google Scholar
• Wu A H, Abbas S A, Green S, et al. Prognostic value of cardiac troponin T in unstable angina pectoris. Am J Cardiol 1995; 76: 970–2
   PubMed Web of Science ®Google Scholar
• de Winter R J, Koster R W, Schotveld J H, Sturk A, van Straalen J P, Sanders G T. Prognostic value of troponin T, myo-globin, and CK-MB mass in patients presentering with chest pain without acute myocardial infarction. Heart 1996; 75: 235–239
   PubMed Web of Science ®Google Scholar
• Cokkinos D V, Kouvaras G. Exercise testing after acute myocardial infarction. How much? How soon?. Acta Cardiol 1990; 45: 75–85
   PubMed Web of Science ®Google Scholar
• Nyman I. Signs and implications of ischemia in unstable coronary artery disease. Thesis, Linköping 1993
   Google Scholar
• Krüger D, Stierle U, Kerner W, et al. No release of troponin T after short-lasting severe myocardial ischemia. Eur Heart J 1994; 15: 221, (abstract)
   Google Scholar
• Jurlander B, Molani M A, Balu D, Ellis A K. Serum troponin T levels predicts coronary angigraphic findings in patients with unstable angina. Circulation 1995; 92: 1–679, (Abstract)
   PubMed Web of Science ®Google Scholar
• Kondo K, Aoki H, Ohira K, et al. Does increased serum troponin T indicate clinical severity in unstable angina?. Eur Heart J 1994; 15: 1208, Abstract Supplement
   Google Scholar
• Wilson R F, Marcus M L, Christensen B V, Talman C, White C W. Accuracy of exercise electrocardiography in detecting physiologically significant coro-nary arterial lesions. Circulation 1991; 83: 412–21
   PubMed Web of Science ®Google Scholar
• Lewis B S, Poole W P. The DEFIANT study of left ventricular function and exercise performance after acute myocardial infarction. Doppler Flow and Echocardiology in Functional Cardiac Insufficiency: Assessment of Nisoldipine Therapy Study Group. Cardiovasc Drugs Ther 1994; 2: 407–18
   Google Scholar